Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05862805 · ClinicalTrials.gov registry record · Phase 1
PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis
A Phase 1 study of Menstrual Bleeding, Heavy, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05862805 is a Phase 1 study of Menstrual Bleeding, Heavy that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05862805, a Phase 1 study of Menstrual Bleeding, Heavy, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to learn more about the role of blood clotting factor proteins and cells in menstrual (period) bleeding. The investigators are hoping to identify differences in these proteins and cells in the menstrual blood of individuals with heavy periods compared to menstruating individuals who do not have heavy periods.
Conditions Studied
Interventions
- PROCEDURE Sample Collection and Endometrial Biopsy
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2026-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05862805
The ClinicalTrials.gov registry entry for NCT05862805 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menstrual Bleeding, Heavy appearing as the primary indexed condition, and to 1 intervention - of which Sample Collection and Endometrial Biopsy is the first listed.
NCT05862805 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT05862805 about?
NCT05862805 is a clinical study titled "PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis". The purpose of the study is to learn more about the role of blood clotting factor proteins and cells in menstrual (period) bleeding. The investigators are hoping to identify differences in these proteins and cells in the menstrual blood of individuals with heavy periods compared to menstruating indi...
What is the current status of trial NCT05862805?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2023-07-12. Estimated completion is 2026-07.
What conditions does trial NCT05862805 study?
This clinical trial studies the following conditions: Menstrual Bleeding, Heavy.
What interventions are being tested in trial NCT05862805?
The interventions under investigation include: Sample Collection and Endometrial Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05862805?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05862805 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menstrual Bleeding, Heavy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.